http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H04244091-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7ad58d3c0b071069a8ee0cb8c8ba2e8
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-572
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-572
filingDate 1991-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fdefce6b92164697003e779aab68595
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a256289d1165270415c0ca39381793ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_506f944f33f14048c25a2ba2268b7bcb
publicationDate 1992-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H04244091-A
titleOfInvention Phosphonopyrrolidine-and piperidine-containing statin-type pseudo-peptides, their production and use as medicine against retrovirus
abstract PURPOSE: To obtain a new compound having excellent anti-viral, paticularly anti-retroviral, activity, and useful for remedy and prevention against HTLV I or II infectious disease, for example, AIDS. n CONSTITUTION: This compound of the formula I and its salts, e.g. 1{(3R,4 S)-4-[(tert-butoxycarbonyl)amino]-5-cyclo-hexyl-3-hydroxypentanoyl}-(2R, S)-2-(pyrrolidinyl)-phosphonic acid diethylester is obtained, for example, by allowing the compound of the formula III to react with the compound denoted by the formula W-X (X is halogen, preferably Cl) in an inactive solvent in the presence of a base. In the formula I, W is H, amino-protecting group, etc.; A, B, D are each direct bond, the formula II ((x) is 1 or 2), etc.; R 1 is ≤10C chain alkyl, 6-10C aryl, etc.; (n) is 1 or 2; R 2 , R 2 ' are each hydroxyl, ≤8C alkoxy; E is CH 2 , CF 2 , etc. n COPYRIGHT: (C)1992,JPO
priorityDate 1990-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID160430489
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452070569
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393653
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310

Total number of triples: 31.